alpelisib
SpainDrugs containing this active substance
-
It is used to treat postmenopausal men and women with a type of advanced breast cancer (hormone receptor-positive and epidermal growth factor receptor 2-negative) that has not responded to other hormonal treatments and presents mutations in the PIK3CA gene.
Form: tablets, film-coated
Active substance Dosage alpelisib 150 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat postmenopausal women and men with a type of advanced breast cancer (hormone receptor-positive and epidermal growth factor receptor 2-negative) that has not responded to other hormonal treatments and presents mutations in the PIK3CA gene.
Form: tablets, film-coated
Active substance Dosage alpelisib 200 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat postmenopausal women and men with a type of advanced breast cancer (hormone receptor-positive and HER2-negative) that has not responded to other hormonal treatments and that has PIK3CA gene mutations.
Form: tablets, film-coated
Active substance Dosage alpelisib 50 mg alpelisib 200 mg Manufacturer: Novartis Europharm Limited